Timber Hill’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-43,777
Closed -$2.77M 101
2018
Q1
$2.77M Sell
43,777
-13,950
-24% -$897K 0.42% 55
2017
Q4
$3.54M Buy
+57,727
New +$3.61M 0.23% 95
2017
Q3
Sell
-13,127
Closed -$731K 645
2017
Q2
$731K Buy
13,127
+9,439
+256% +$514K 0.03% 451
2017
Q1
$201K Sell
3,688
-47,399
-93% -$2.6M ﹤0.01% 1978
2016
Q4
$2.99M Sell
51,087
-16,295
-24% -$891K 0.01% 718
2016
Q3
$3.63M Buy
+67,382
New +$4.33M 0.02% 584
2015
Q4
Sell
-38,803
Closed -$2.56M 2252
2015
Q3
$2.3M Buy
+38,803
New +$2.46M 0.01% 941
2014
Q4
Sell
-45,521
Closed -$2.57M 2514
2014
Q3
$2.33M Sell
45,521
-22,865
-33% -$1.14M 0.01% 1047
2014
Q2
$3.32M Buy
68,386
+52,527
+331% +$2.59M 0.02% 843
2014
Q1
$824K Sell
15,859
-15,997
-50% -$851K ﹤0.01% 1738
2013
Q4
$1.69M Buy
31,856
+26,629
+509% +$1.36M 0.01% 1487
2013
Q3
$242K Buy
+5,227
New +$229K ﹤0.01% 2922

Other funds holding BMY

Timber Hill's BMY Position: Q2 2018 in Review

Timber Hill sold out of Bristol-Myers Squibb (BMY) in Q2 2018, closing a stake of 43,777 shares — an estimated $2.77M sold.

Timber Hill first reported a position in BMY in Q3 2013 and held it in 12 quarters. The position peaked at $3.63M in Q3 2016. 1,691 funds tracked by Wall St. Rank hold BMY as of Q2 2018.

  • Timber Hill reported no remaining Bristol-Myers Squibb position as of Q2 2018 after selling out during the quarter.
  • Timber Hill sold 43,777 Bristol-Myers Squibb shares in Q2 2018, an estimated $2.77M.
  • Timber Hill first reported a position in Bristol-Myers Squibb in Q3 2013 and held it in 12 quarters.
  • Timber Hill's Bristol-Myers Squibb position peaked at $3.63M in Q3 2016.
  • 1,691 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2018.

Based on Timber Hill's 13F filing for Q2 2018, filed 9 Aug 2018.